Objective The novel description of antibodies to lipoprotein lipase (anti‐LPL) associated with
dyslipoproteinemia prompted us to analyze the association of anti‐LPL with clinical and …

Objective. To demonstrate the binding of bovine lipoprotein lipase (LPL) by IgG from sera
obtained from patients with systemic lupus erythematosus (SLE) and other rheumatic …

OBJECTIVE: The vascular damage systemic sclerosis (SSc) consists mainly of
microvascular changes, but recently macrovascular changes with dyslipidemia were …

Introduction: Premature development of atherosclerosis in systemic lupus erythematosus
has been widely reported. Anti-lipoprotein lipase antibody may be one cause contributing to …

Autoimmunity and inflammation are associated with marked changes in lipid and lipoprotein
metabolism in SLE. Autoantibodies and cytokines are able to modulate lipoprotein lipase …

Rheumatoid arthritis is a chronic inflammatory disease, associated with an excess of
cardiovascular morbidity and mortality due to accelerated atherosclerosis. Oxidized low …

Objective Inflammatory disease activity in patients with systemic lupus erythematosus (SLE)
may affect the development of atherosclerosis, contributing to their increased risk of …

Objective Although antiphospholipid antibodies (aPL) are associated with arterial and
venous thrombosis in systemic lupus erythematosus (SLE), the extent to which they …

A growing body of evidences reinforces the close link between systemic lupus
erythematosus (SLE) and atherosclerosis which is due to traditional and nontraditional risk …

Objective To determine whether antiphospholipid antibodies (aPL) occur before the
diagnosis of systemic lupus erythematosus (SLE) and before initial clotting events, and …